JP2010222379A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010222379A5 JP2010222379A5 JP2010150627A JP2010150627A JP2010222379A5 JP 2010222379 A5 JP2010222379 A5 JP 2010222379A5 JP 2010150627 A JP2010150627 A JP 2010150627A JP 2010150627 A JP2010150627 A JP 2010150627A JP 2010222379 A5 JP2010222379 A5 JP 2010222379A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- residues
- fetoprotein
- acid sequence
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 11
- 102000013529 alpha-Fetoproteins Human genes 0.000 claims 4
- 108010026331 alpha-Fetoproteins Proteins 0.000 claims 4
- 108090000765 processed proteins & peptides Proteins 0.000 claims 4
- 206010028980 Neoplasm Diseases 0.000 claims 3
- 125000003275 alpha amino acid group Chemical group 0.000 claims 3
- 201000011510 cancer Diseases 0.000 claims 3
- 210000004027 cell Anatomy 0.000 claims 3
- 230000028993 immune response Effects 0.000 claims 3
- 101000827785 Homo sapiens Alpha-fetoprotein Proteins 0.000 claims 2
- 101000848653 Homo sapiens Tripartite motif-containing protein 26 Proteins 0.000 claims 2
- 239000002299 complementary DNA Substances 0.000 claims 2
- 210000004443 dendritic cell Anatomy 0.000 claims 2
- 239000012634 fragment Substances 0.000 claims 2
- 102000046101 human AFP Human genes 0.000 claims 2
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 1
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 claims 1
- 206010073071 hepatocellular carcinoma Diseases 0.000 claims 1
- 231100000844 hepatocellular carcinoma Toxicity 0.000 claims 1
- 150000007523 nucleic acids Chemical group 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3837597P | 1997-02-13 | 1997-02-13 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006038626A Division JP2006188528A (ja) | 1997-02-13 | 2006-02-15 | 肝細胞癌の予防又は処置のための組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010222379A JP2010222379A (ja) | 2010-10-07 |
| JP2010222379A5 true JP2010222379A5 (enExample) | 2010-11-18 |
Family
ID=21899585
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP53591698A Expired - Lifetime JP3816959B2 (ja) | 1997-02-13 | 1998-02-13 | 肝細胞癌の予防および処置 |
| JP2006038626A Withdrawn JP2006188528A (ja) | 1997-02-13 | 2006-02-15 | 肝細胞癌の予防又は処置のための組成物 |
| JP2010150627A Pending JP2010222379A (ja) | 1997-02-13 | 2010-06-30 | 肝細胞癌の予防又は処置のための組成物 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP53591698A Expired - Lifetime JP3816959B2 (ja) | 1997-02-13 | 1998-02-13 | 肝細胞癌の予防および処置 |
| JP2006038626A Withdrawn JP2006188528A (ja) | 1997-02-13 | 2006-02-15 | 肝細胞癌の予防又は処置のための組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20020031520A1 (enExample) |
| EP (1) | EP0979239B1 (enExample) |
| JP (3) | JP3816959B2 (enExample) |
| KR (1) | KR100460583B1 (enExample) |
| CN (2) | CN1739791A (enExample) |
| AU (1) | AU6435398A (enExample) |
| DE (1) | DE69836209D1 (enExample) |
| WO (1) | WO1998035981A1 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100482920B1 (ko) * | 2000-02-10 | 2005-04-14 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | 간세포암을 치료하기 위한 조성물 |
| FI118263B (fi) * | 2002-10-09 | 2007-09-14 | Timo Kalevi Korpela | Kaspaasiaktiivisuutta säätelevät peptidit |
| US8932829B2 (en) | 2005-07-07 | 2015-01-13 | Elena Dudich | Recombinant alpha-fetoprotein and compositions thereof |
| GB0617564D0 (en) * | 2006-09-06 | 2006-10-18 | Ucl Business Plc | Peptides and methods |
| KR100900742B1 (ko) * | 2007-05-17 | 2009-06-08 | 크레아젠 주식회사 | 인간 간암 동물모델 및 이를 이용한 수지상세포-유래 간암면역치료제의 예방 및 치료 효능을 분석하는 방법 |
| US20120270238A1 (en) * | 2009-10-22 | 2012-10-25 | Moro Ricardo J | Peptides That Bind the Alpha-Fetoprotein (AFP) Receptor and Uses Thereof |
| CN105121715B (zh) | 2012-12-11 | 2018-10-26 | 艾伯特叶史瓦大学爱因斯坦医学院 | 高通量受体:配体鉴定方法 |
| KR102721595B1 (ko) | 2015-04-03 | 2024-10-23 | 유레카 쎄라퓨틱스, 인코포레이티드 | Afp 펩티드/mhc 복합체를 표적화하는 구축물 및 그의 용도 |
| CN105126074A (zh) * | 2015-09-30 | 2015-12-09 | 中国药科大学 | 多肽afp12在制备抗肿瘤药物中的应用 |
| CN105524884A (zh) * | 2016-02-29 | 2016-04-27 | 时宏珍 | Hla-a0201限制性抗afp抗原特异性ctl的制备方法 |
| CA3022331A1 (en) | 2016-05-18 | 2017-11-23 | Albert Einstein College Of Medicine, Inc. | Variant pd-l1 polypeptides, t-cell modulatory multimeric polypeptides, and methods of use thereof |
| CN109475628A (zh) | 2016-05-18 | 2019-03-15 | 库尔生物制药有限公司 | T细胞调节性多聚体多肽及其使用方法 |
| AU2017379900B2 (en) | 2016-12-22 | 2024-12-05 | Cue Biopharma, Inc. | T-cell modulatory multimeric polypeptides and methods of use thereof |
| WO2018129474A1 (en) | 2017-01-09 | 2018-07-12 | Cue Biopharma, Inc. | T-cell modulatory multimeric polypeptides and methods of use thereof |
| EP3596118B1 (en) | 2017-03-15 | 2024-08-21 | Cue Biopharma, Inc. | Combination of multimeric fusion polypeptides and immune checkpoint inhibitor for treating hpv-associated cancer |
| WO2019139896A1 (en) | 2018-01-09 | 2019-07-18 | Cue Biopharma, Inc. | Multimeric t-cell modulatory polypeptides and methods of use thereof |
| EP4149534A4 (en) | 2020-05-12 | 2024-09-04 | Cue Biopharma, Inc. | MULTIMERIC POLYPEPTIDES MODULATING T CELLS AND METHODS OF USE THEREOF |
| WO2022056014A1 (en) | 2020-09-09 | 2022-03-17 | Cue Biopharma, Inc. | Mhc class ii t-cell modulatory multimeric polypeptides for treating type 1 diabetes mellitus (t1d) and methods of use thereof |
| CN113416729B (zh) * | 2021-05-18 | 2022-11-22 | 遵义医科大学附属医院 | 一种肝脏靶向调控甲胎蛋白基因的shRNA和cDNA及其应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH025866A (ja) * | 1988-06-27 | 1990-01-10 | Kansai Shin Gijutsu Kenkyusho:Kk | ヒトアルファフェトプロテインドメインｉ遺伝子、対応プラスミド組換体、対応形質転換体、該ドメインｉの製造法及び製造された該ドメインｉ |
| IT1226551B (it) * | 1988-07-29 | 1991-01-24 | Sclavo Spa | Peptide sintetico immunologicamente attivo capace di indurre la produzione di anticorpi con elevata specificita' verso l'alfa- fetoproteina e loro impiego in campo diagnostico |
| US5633234A (en) * | 1993-01-22 | 1997-05-27 | The Johns Hopkins University | Lysosomal targeting of immunogens |
| US5593972A (en) * | 1993-01-26 | 1997-01-14 | The Wistar Institute | Genetic immunization |
| AU700975B2 (en) * | 1995-01-24 | 1999-01-14 | Merrimack Pharmaceuticals, Inc. | Recombinant human alpha-fetoprotein and uses thereof |
-
1998
- 1998-02-13 JP JP53591698A patent/JP3816959B2/ja not_active Expired - Lifetime
- 1998-02-13 KR KR10-1999-7008375A patent/KR100460583B1/ko not_active Expired - Lifetime
- 1998-02-13 AU AU64353/98A patent/AU6435398A/en not_active Abandoned
- 1998-02-13 CN CNA2005100915162A patent/CN1739791A/zh active Pending
- 1998-02-13 DE DE69836209T patent/DE69836209D1/de not_active Expired - Lifetime
- 1998-02-13 EP EP98910001A patent/EP0979239B1/en not_active Expired - Lifetime
- 1998-02-13 CN CNB988052288A patent/CN1222536C/zh not_active Expired - Lifetime
- 1998-02-13 WO PCT/US1998/002753 patent/WO1998035981A1/en not_active Ceased
-
1999
- 1999-08-12 US US09/373,913 patent/US20020031520A1/en not_active Abandoned
-
2006
- 2006-02-15 JP JP2006038626A patent/JP2006188528A/ja not_active Withdrawn
-
2010
- 2010-06-30 JP JP2010150627A patent/JP2010222379A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010222379A5 (enExample) | ||
| ES2545895T3 (es) | Proteína de fusión anticancerígena | |
| JP2015525217A5 (enExample) | ||
| JP2014525439A5 (enExample) | ||
| MX337417B (es) | Vacunas peptidicas para canceres que expresan antigenos asociados con tumores. | |
| JP2009268467A5 (enExample) | ||
| JP2014224126A5 (enExample) | ||
| JP2015134796A5 (enExample) | ||
| CY1116099T1 (el) | Πρωτεϊνη συντηξης κατα του καρκινου | |
| MX2021000030A (es) | Metodos y composiciones que utilizan polipeptidos variantes klotho. | |
| MX2020010806A (es) | Peptidos anti-inflamatorios y usos de los mismos. | |
| ES2545457T3 (es) | Vacunas de péptidos para cánceres que expresan los polipéptidos DEPDC1 | |
| JP2015528443A5 (enExample) | ||
| JP2015514395A5 (enExample) | ||
| NZ705899A (en) | Inhibiting peptides derived from triggering receptor expressed on myeloid cells-1 (trem-1) trem-like transcript 1 (tlt-1) and uses thereof | |
| CO6430475A2 (es) | Polipéptidos que tienen actividad de celulasa | |
| EP2589658A4 (en) | PARTIAL REGION POLYPEPTIDE OF REIC / DKK-3 PROTEIN | |
| FI3737399T3 (fi) | ATF5-peptidivariantit ja niiden käytöt | |
| JP2014047156A5 (enExample) | ||
| JP2013517764A5 (enExample) | ||
| JP2013523084A5 (enExample) | ||
| HRP20240359T1 (hr) | Peptidi iz piwil1 | |
| JP2012526519A5 (enExample) | ||
| JP2012527867A5 (enExample) | ||
| NZ591133A (en) | Novel melanoma antigen peptide and uses thereof |